European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

10th SEEM: Rationale for salvage LND in prostate cancer

Fri, 24 Oct 2014

Salvage lymph node dissection in locally advanced prostate cancer is a viable option but requires careful patient selection and the use of suitable imaging techniques, according to Prof. Bob Djavan (AT) during the EAU lecture he presented at the first day of the 10th South Eastern European Meeting (SEEM) in Belgrade, Serbia.

“Salvage lymph node dissection might be considered an intriguing option which is still under investigation, and only if a correct patient selection is made. Patient selection remains key,” said Djavan.

Around 500 participants gathered in Belgrade for the 10th SEEM, the third time Serbia is hosting the annual event organised by the Regional Office.

In his keynote lecture, Djavan focused on patients with locally advanced prostate cancer who have recurrent disease in their lymph nodes despite previous medical or surgical interventions. With the southeastern European region having one of the highest incidence of recurrent prostate disease, Djavan said that it is crucial for urologists to consider the option of a secondary lymph node dissection.

There are caveats or careful requirements before taking this option, according to Djavan as he underscored the need for urologists to use the appropriate imaging technique such as choline PET scan. He also noted that standard MRI will not be helpful, considering its lower sensitivity and accuracy rates.

Another consideration is determining if the patient belongs to the right selection group. “Patients with secondary biochemical recurrence is highly heterogeneous, it is therefore crucial to satisfy the requirement of care patient selection,” he added.

The following are his key messages:

• The rationale for salvage LND might reside in the nodal mestastatizing spread of PCa which still need to be elucidated ;

• The prerequisite for any non-systemic salvage approach is the availability of accurate and sensitive imaging modality for detecting nodal recurrence;

• There are few studie, including approximately 200 patients are available in the literature, and all of them are limited by heterogeneous patient population and limited follow-up

Share this article

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer